Works matching DE "FATTY liver"

Results: 5000
    1
    2
    3
    4
    5

    Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association.

    Published in:
    Diabetes Care, 2025, v. 48, n. 7, p. 1057, doi. 10.2337/dci24-0094
    By:
    • Cusi, Kenneth;
    • Abdelmalek, Manal F.;
    • Apovian, Caroline M.;
    • Balapattabi, Kirthikaa;
    • Bannuru, Raveendhara R.;
    • Barb, Diana;
    • Bardsley, Joan K.;
    • Beverly, Elizabeth A.;
    • Corbin, Karen D.;
    • ElSayed, Nuha A.;
    • Isaacs, Scott;
    • Kanwal, Fasiha;
    • Pekas, Elizabeth J.;
    • Richardson, Caroline R.;
    • Roden, Michael;
    • Sanyal, Arun J.;
    • Shubrook, Jay H.;
    • Younossi, Zobair M.;
    • Bajaj, Mandeep
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Epidemiological trends and burden of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa region: a 32-year analysis of health impact.

    Published in:
    Journal of Health, Population & Nutrition, 2025, v. 44, n. 1, p. 1, doi. 10.1186/s41043-025-00973-5
    By:
    • Sarkoohi, Zahra;
    • Bastan, Mohammad-Mahdi;
    • Khajuei Gharaei, Mohammad Amin;
    • Iranmanesh, Mahsa;
    • Adinepour, Arya;
    • Khajezade, Reyhane;
    • Bahri, Faegheh;
    • Akhlaghi, Fatemeh;
    • Kadkhodamanesh, Azin;
    • Pourghadamyari, Hossein;
    • Sharifi, Hamid;
    • Eslami, Omid;
    • Nejadghaderi, Seyed Aria
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    儿童风湿病与肝脏病变.

    Published in:
    Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2025, v. 41, n. 5, p. 823, doi. 10.12449/JCH250505
    By:
    • 孙, 菲;
    • 毛, 华伟
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, p. 3, doi. 10.1111/dom.16496
    By:
    • Zargar, Abdul Hamid;
    • Bhansali, Anil;
    • Majumdar, Anirban;
    • Maheshwari, Anuj;
    • Bhattacharyya, Arpandev;
    • Dasgupta, Arundhati;
    • Saboo, Banshi Damodarlal;
    • Sethi, Bipin Kumar;
    • Sanyal, Debmalya;
    • Seshadri, Krishna G.;
    • Deshpande, Neeta Rohit;
    • Kapoor, Nitin;
    • Lakhani, Om Jitendra;
    • Talwalkar, Pradeep Gopal;
    • Kalra, Pramila;
    • Mehrotra, Rabindera Nath;
    • Sahay, Rakesh Kumar;
    • Shukla, Rishi;
    • Kant, Saket;
    • Das, Sambit
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47

    The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver disease.

    Published in:
    PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0307345
    By:
    • Grandt, Josephine;
    • Johansen, Christian D.;
    • Jensen, Anne-Sofie H.;
    • Werge, Mikkel P.;
    • Rashu, Elias B.;
    • Møller, Andreas;
    • Junker, Anders E.;
    • Hobolth, Lise;
    • Mortensen, Christian;
    • Vyberg, Mogens;
    • Serizawa, Reza Rafiolsadat;
    • Møller, Søren;
    • Gluud, Lise Lotte;
    • Wewer Albrechtsen, Nicolai J.
    Publication type:
    Article
    48
    49
    50